Phone-Based cholesterol coaching after heart attack shows promise

NCT ID NCT07685639

Not yet recruiting Disease control Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether a proactive, pharmacist-led telephone program can help people who have had a heart attack reach safer cholesterol levels. Participants receive pharmacist calls, repeat blood tests, and medication adjustments based on national guidelines. The goal is to see if this approach increases the number of patients who achieve an LDL cholesterol target below 1.8 mmol/L at six months, compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pharmacist-led lipid optimization pathway (telephone clinic)
What this could lead to: If successful, this approach could become a standard way to help heart attack survivors achieve healthier cholesterol levels and lower their risk of future heart attacks or strokes.
What could go wrong: This is a quality improvement study, not a test of a new drug. The results may not apply outside Alberta, and the program may not work as well in other healthcare settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACS (ACUTE CORONARY SYNDROME) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute chest syndrome acute coronary syndrome Dyslipidemias hyperlipidemia inherited lipid metabolism disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACS (ACUTE CORONARY SYNDROME) DYSLIPIDEMIA HYPERLIPIDEMIA LOW-DENSITY-LIPOPROTEIN-CHOLESTEROL LEVEL

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.